ARL 15849XX
| Code | Size | Price |
|---|
| TAR-T25108-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
ARL 15849XX, a CCK-8 analog, is a novel anti-obesity agent.
CAS:
152548-39-5
Formula:
C47H60N8O13S
Molecular Weight:
977.1
Purity:
0.98
SMILES:
CCCC[C@H](NC(=O)Cc1ccc(OS(O)(=O)=O)cc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
References
1. Willson VJ, Preston JR, Lockley WJ, Singh J, Wilkinson D. A radioimmunoassay combined with solid-phase extraction for the determination of a novel anti-obesity agent, ARL 15849XX, in dog plasma. J Pharm Biomed Anal. 1996 Mar;14(5):593-600. PubMed PMID: 8738189.
2. Simmons RD, Kaiser FC, Hudzik TJ. Behavioral effects of AR-R 15849, a highly selective CCK-A agonist. Pharmacol Biochem Behav. 1999 Mar;62(3):549-57. PubMed PMID: 10080250.